ARCHIVES

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill

June 14, 1974

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999